Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5172710012 | Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5172711011 | Product containing precisely brimonidine (as brimonidine tartrate) 3.3 milligram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel | Has manufactured dose form | Cutaneous gel | true | Inferred relationship | Some | ||
| Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel | Has precise active ingredient | Brimonidine tartrate (substance) | true | Inferred relationship | Some | 1 | |
| Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel | Has basis of strength substance (attribute) | Brimonidine (substance) | true | Inferred relationship | Some | 1 | |
| Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel | Is a | Product containing only brimonidine in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR